文献速递衰弱、肌少症与跌倒老年慢病共病管理

美国住院新诊断房颤老年患者口服抗凝启动情况

Initiation of oral anticoagulation in US older adults newly diagnosed with atrial fibrillation during hospitalization.
PubMed 文献 · J Am Geriatr Soc · 2023-04-24

基于2016年20% Medicare按服务收费受益人样本,纳入住院期间新诊断房颤的65岁及以上患者38,379例,主要结局为出院后7天内口服抗凝药索赔。符合条件的患者中仅24.6%启动口服抗凝,衰弱与较高HAS-BLED评分与启动概率降低相关,因非心血管病或出血住院者启动概率最低。

要点

  • 住院新诊断房颤且符合抗凝指征的老年患者中,仅24.6%在出院后7天内启动口服抗凝药。
  • CHA2DS2-VASc评分≥4者启动概率24.9%,评分<2者为20.5%。
  • 中度至重度衰弱者启动概率18.1%,非衰弱者24.7%;因出血住院者最低为3.6%。

核心结论

  • 住院期间新诊断房颤的老年患者中口服抗凝启动不常见,即使以房颤为主要住院原因或血栓栓塞风险高者亦然。
  • 作者建议临床医生应与所有发现房颤的住院患者讨论口服抗凝药的风险与获益。

研究设计与样本

  • 基于2016年20%全国Medicare按服务收费受益人样本,识别住院期间新诊断房颤的65岁及以上患者。
  • 主要结局为出院后7天内口服抗凝药索赔;采用多变量logistic回归分析抗凝启动与血栓栓塞及出血风险评分的关系,并控制人口学、衰弱、共病和住院特征。

主要发现

  • 共纳入38,379例住院新诊断房颤老年患者(平均年龄78.2岁[SD 8.4];女性51.8%;白人83.3%)。
  • 36,633例(95.4%)有抗凝指征,其中24.6%(9011例)在出院后启动口服抗凝药。
  • CHA2DS2-VASc评分较高与口服抗凝启动小幅增加相关:评分<2预测概率20.5%(95%CI 18.7%-22.3%),≥4为24.9%(95%CI 24.4%-25.4%)。
  • HAS-BLED评分升高与抗凝启动概率小幅降低相关:评分<2为25.4%(95%CI 24.4%-26.4%),≥3为23.1%(95%CI 22.5%-23.8%)。
  • 衰弱与口服抗凝启动可能性降低相关:非衰弱者24.7%(95%CI 23.2%-26.2%),中度至重度衰弱者18.1%(95%CI 16.6%-19.6%)。

关键数值与推荐

  • 有抗凝指征患者定义为36,633例(占38,379例的95.4%)。
  • 出院后7天内口服抗凝药索赔为启动的判定标准。

临床怎么用

  • 临床医生应与所有住院期间发现房颤的患者讨论口服抗凝药的风险与获益。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation is a common cause of stroke among older adults and is often first detected during hospitalization, given frequent use of cardiac telemetry. METHODS: In a 20% national sample of Medicare fee-for-service beneficiaries, we identified patients aged 65-or-older newly diagnosed with atrial fibrillation while hospitalized in 2016. Our primary outcome was an oral anticoagulant claim within 7-days of discharge. Multivariable logistic regression analyses assessed relationships between anticoagulation initiation and thromboembolic and bleeding risk scores while controlling for demographics, frailty, comorbidities, and hospitalization characteristics. RESULTS: Among 38,379 older adults newly diagnosed with atrial fibrillation while hospitalized (mean age 78.2 [SD 8.4]; 51.8% female; 83.3% white), 36,633 (95.4%) had an indication for anticoagulation and 24.6% (9011) of those initiated an oral anticoagulant following discharge. Higher CHA2 DS2 -VASc score was associated with a small increase in oral anticoagulant initiation (predicted probability 20.5% [95% CI, 18.7%-22.3%] for scores <2 and 24.9% [CI, 24.4%-25.4%] for ≥4). Elevated HAS-BLED score was associated with a small decrease in probability of anticoagulant initiation (25.4% [CI, 24.4%-26.4%] for score <2 and 23.1% [CI, 22.5%-23.8%] for ≥3). Frailty was associated with decreased likelihood of oral anticoagulant initiation (24.7% [CI, 23.2%-26.2%] for non-frail and 18.1% [CI, 16.6%-19.6%] for moderately-severely frail). Anticoagulant initiation varied by primary reason for hospitalization, with predicted probability highest among patients with a primary diagnosis of atrial fibrillation (46.1% [CI, 45.0%-47.3%]) and lowest among those with non-cardiovascular conditions (13.8% [CI, 13.3%-14.3%]) and bleeds (3.6% [CI, 2.4%-4.8%]). CONCLUSIONS: Oral anticoagulant initiation is uncommon among older adults newly diagnosed with atrial fibrillation during hospitalization, even among patients hospitalized primarily for atrial fibrillation and patients with high thromboembolic risk. Clinicians should discuss risks and benefits of oral anticoagulants with all inpatients found to have atrial fibrillation.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Troy AL, Herzig SJ, Trivedi S, et al. Initiation of oral anticoagulation in US older adults newly diagnosed with atrial fibrillation during hospitalization. J Am Geriatr Soc. 2023. PMID: 37092856. doi:10.1111/jgs.18375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。